Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 telotristat etiprate add-on study in carcinoid syndrome inadequately controlled by somatostatin analog therapy
NL-OMON41315Phase 3Active, not recruiting
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of telotristat ethyl, sponsored by Lexicon Pharmaceuticals, Inc. Started Feb 2014; status: active, not recruiting.
02
Drugs
telotristat ethyl
Beyond the preview
Go deeper on NL-OMON41315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41315.